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Background—The breast imaging modalities of mammography, ultrasound, and magnetic
resonance imaging (MRI) are widely used for screening, diagnosis, treatment, and surveillance of
breast cancer. Geographic access to breast imaging modalities is not known at a national level
overall or for population subgroups.
Methods—A retrospective study of 2004-2008 Medicare claims data to identify ZIP codes in
which breast imaging occurred, and data were mapped. We estimated travel times to each
modality for 215,798 census block groups in the contiguous U.S. Using Census 2010 data, we
characterized travel times by socio-demographic factors for 92,788,909 women aged ≥30 years,
overall, and by subgroups of age, race/ethnicity, rurality, education, and median income.
Results—Overall, 85% of women had travel times of ≤20 minutes to nearest mammography or
ultrasound, and 70% had travel times of ≤20 minutes for MRI with little variation by age. Native
American women had median travel times 2-3-fold longer to all three modalities, compared to
women of other racial/ethnic groups. For rural women, median travel times to breast imaging were
4-8-fold longer than for urban women. Black and Asian women had shortest median travel times
to all three modalities.
Conclusion—Travel times to mammography and ultrasound breast imaging are short for most
women, but to breast MRI travel times are notably longer. Native American and rural women are
disadvantaged in geographic access based on travel times to breast imaging. This work informs
potential interventions to reduce inequities in access and utilization.
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Introduction
Breast imaging is a key component of screening, diagnosis, treatment, and surveillance for
breast cancer. Evidence-based U.S. guidelines recommend biennial mammography for
average-risk women ages 50-74 years, with a preference-based approach for women ages
40-49 years [1]. Every year in the U.S., approximately 37 million screening and diagnostic
mammograms are performed [2]. This translates to an estimated 70% of women aged 50-74
years undergoing screening mammography biennially, with between 9-14% receiving
further diagnostic breast imaging (mammography, ultrasound, MRI) and/or biopsy [3]. The
full scope of use of breast ultrasound and breast MRI is not known, but these are important
breast imaging modalities for specific clinical scenarios. Ultrasound is predominantly used
in the diagnostic work-up of imaging or clinical findings, and potentially screening a subset
of women at increased breast cancer risk. Although there are few data supporting its use for
screening based solely on higher mammographic breast density use of additional imaging
technologies might be more common as breast density reporting laws are implemented.
Recently passed breast density reporting laws in several states mandate that women with
dense breasts be directly informed of their increased cancer risk and may benefit from
supplemental screening beyond mammography [4]. Breast MRI is currently the most
sensitive test for breast cancer detection, and is recommended by groups including the
American Cancer Society (ACS) and the National Comprehensive Cancer Network (NCCN)
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annually as an adjunct to mammography for screening of women at high risk for breast
cancer [5,6]. Overall, mammography, ultrasound, and MRI or a combination of these
examinations are critical in detecting, diagnosing and characterizing extent of breast cancer,
and also in excluding malignancy of the breast. For each of the major clinical areas in which
breast imaging is used, geographic access may determine both the availability and uptake of
breast imaging services [7-11], which in turn may influence treatment decisions and
ultimately outcomes [12,13].
Prior studies have shown that longer travel time to care is associated with lower utilization
of specialized services. For example, evidence suggests that travel time to breast imaging
facilities may influence women's utilization of breast cancer treatment, with longer travel
times associated with a greater likelihood of mastectomy instead of breast-conserving
surgery [8, 10]. However, there is a lack of evidence regarding travel times required for
different breast imaging modalities, despite the fact that the modalities of mammography,
ultrasound and breast MRI comprise the core of recommended screening and diagnostic
imaging tests. While women's ability to utilize breast services is multifactorial, proximity of
services and travel time burden is one important component that warrants consideration
[15-17]. Vulnerable populations have poorer access to health care resources [18-21], which
may be due in part to geographic access barriers.
Our manuscript examines travel time to three types of breast imaging services--
mammography, ultrasound, and MRI- for ZIP code areas of the continental U.S. We
describe population characteristics in relation to travel time for each of these breast imaging
modalities, and provide an overall view of geographic access to breast imaging in the U.S.
for subgroups of women.
Methods
Study Population and Data
We used 2010 Census data to determine the number of women aged 30 years and older in
each census block group of the contiguous U.S. [22]. The age criterion was based on ACS
guidelines, which recommend screening mammograms for high-risk women starting at age
30, as well as recognizing that an estimated 12,000 women under age 40 are diagnosed with
breast cancer each year [23, 24]. We excluded Alaska and Hawaii due to the lack of quality
road based geospatial data. Population characteristics were based on the U.S. Census 2010
and included: age, race/ethnicity, education and median household income at the block
group level. Rurality is based on the four-tier rural-urban commuting area (RUCA)
designation [25, 26]. Briefly, these designations are made based on commuting patterns of
the population for given areas, and include: 1. Urban Core; 2. Sub-Urban; 3. Large Rural
Town; 4. Small Town/Isolated Rural [25,26].
Location of Breast Imaging Modalities
We took a utilization-based approach to identify breast imaging location, similar to prior
studies [27-30]. Specifically, using a 20% sample of Medicare Part B claims data (Carrier
and Outpatient files) from 2004 -2008, we identified claims and the associated ZIP codes for
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mammography, breast ultrasound, and breast MRI using ICD-9 and Current Procedural
Terminology (CPT) codes (Table 4). 5,846 unique ZIP codes were identified of which 5,497
provided mammography, 5,046 breast ultrasound, and 1,783 breast MRI. We used ArcGIS
v10.1 to geocode each of these breast imaging modalities to the related ZIP code centroid.
Travel Time Calculation
We obtained the TIGER/Line shapefiles [31] and calculated the centroid of each block
group. Using the Network Analyst extension in ArcGIS v.10.1 and the Streetmap North
America (N.A.) network dataset [32], we calculated travel time from each block group
centroid to the nearest facility offering: 1) mammography, 2) breast ultrasound, and 3) breast
MRI. Continuous measures of travel time were generated for the contiguous U.S. for each
modality. We categorized these times into (minutes): <=30, 31 – 60, and >60 to generate a
national map (Figure 1).
Analyses
We summarized the number of women aged 30 years and older for each travel time category
and for each breast imaging modality. We then calculated the median and interquartile range
of continuous travel time estimates for each modality, and the median travel times for
population subgroups, including age, race/ethnicity, rurality, education, and median
household income. Some research has shown that health care utilization is diminished if a
service is more than 20 miles away [33], and several state health departments have
advocated for no more than 30 minutes of travel for rural patients to see a physician [34].
All analyses were performed with Stata® v.11.2.
Results
Travel time categories (minutes) for each of the 215,798 block groups in the contiguous U.S.
were mapped to visually compare travel times by geographic location and by modality
(Figure 1). A total of 92,788,909 women aged 30 years and above were included in the
population estimates for travel time. The majority of these women lived within 10 minutes
of the nearest mammography and breast ultrasound services (67.2% and 65.8%), while just
under half (48.7%) lived that close to breast MRI (Table 1). Approximately 85% of the 30+
female population had 20 minutes or less travel time to nearest mammography or
ultrasound. Breast MRI had the highest proportion of women living >20 minutes from the
nearest location (29%) (Table 1). There were no notable differences in the proportion of
women in each travel time category by age (Table 5).
The overall median travel time to nearest mammography or ultrasound was 6 minutes
(interquartile range [IQR], 4-13 minutes); for breast MRI it was 10 minutes (IQR, 5-26)
(Table 2). Median travel times to the three breast imaging modalities differed markedly by
population characteristics. Native American women had longer median travel times to all
breast imaging modalities compared to the other racial/ethnic subgroups (Table 2). For
breast MRI, Native Americans had median travel times that were twice as long as that of
White women (median=24 min; IQR, 8-72, and 12 min; IQR 6-27, respectively), and three
times longer than for other racial groups (Table 2). Median travel times for all breast
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imaging modalities were shorter for Black women compared to White women (Table 2).
Travel time to MRI increased as rurality increased. For mammography and ultrasound,
however, Sub-Urban areas had longer travel times than Large Rural Town areas (median for
mammography: Sub-Urban, 19; IQR, 13-26, Large Rural Town, 8; IQR, 4-18). No notable
differences in median travel times by education or median household income were seen
(Table 2).
For mammography and ultrasound, only about 5% of the female population age 30+ had
greater than 30 minutes travel time. For breast MRI, the proportion was almost quadruple
that (19.8%) (Table 3). The proportion of the Native American women age 30+ population
with >30 minutes travel time to mammography and ultrasound was more than triple that for
White women (39.6% v. 12.6%), and about 6 times higher than for Black women (6.4%)
and Pacific Islander women (7.2%). Asian women had the lowest proportion (∼2%) of
women with travel time >30 minutes to mammography and ultrasound (Table 3). In relation
to rurality, the proportion of women with travel time >30 minutes for breast MRI was high
for all but Urban Core, but for mammography and ultrasound only Small Town/Isolated
Rural Areas had a notably high proportion (Table 3). We examined the extent to which the
effects of rurality and race/ethnicity were independently associated with travel time, and
found that travel times for Native American women were longer regardless of rurality (Table
6). Differences in the proportion of women with a >30 minutes travel time to breast imaging
modalities were modest in relation to educational attainment, but by income, women in the
4th income quartile (lowest) had the lowest proportion in the >30 minutes travel time
category for all imaging modalities (Table 3).
Discussion
This study is the first to provide data regarding U.S. geographic access to the three most
common breast imaging modalities. We found that the vast majority of women age 30 and
older live within 30 minutes of mammography, breast ultrasound, and breast MRI.
Geographic access was similar for mammography and ultrasound, but notably less for MRI.
Marked differences in the proportion of women with a travel time of greater than 30 minutes
to the nearest MRI were seen by race/ethnicity, rurality, and area-level median household
income. A much higher proportion of Native American women had travel times of >30
minutes for all breast imaging modalities, compared to other racial/ethnic subgroups. A
lower proportion of black compared to white women had >30 minutes of travel time to all
three breast imaging modalities. A high proportion of rural women had >30 minutes travel
time for all breast imaging, and most notably for MRI (86%). Interestingly, the lowest
income quartile had the lowest proportion with >30 minutes travel time, suggesting that
geographic access is not a likely barrier to utilization in this group, although transportation
and other factors may be.
We found that geographic access to breast MRI is the most limited among the breast
imaging modalities studied. A phenomenon that is likely to be more pronounced with even
new advance technologies such as digital breast tomosynthesis. There are multiple factors
that could contribute to the more limited geographic availability of MRI, including the
relatively higher expense of the equipment, and lower workforce capacity with expertise in
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this advanced technology. Diffusion of advanced technologies often occurs unevenly, and
may in fact, never reach all geographic areas due to resource allocation strategies, such as
certificates of need and creation of high-volume referral centers. MRI use has increased by
3.2%-11.5% annually from 2004-2008 based on national Medicare data samples [35,36].
This increase in advanced imaging use varies geographically by as much as 2-fold when
examined at the level of the 10 national regions specified by the Centers for Medicaid and
Medicare Services (CMS) [37].
Variation in geographic access by race/ethnicity and rurality has potential implications for
fully understanding mechanisms underlying disparities in health care utilization and
outcomes. For example, the approximately 2.5 million women aged 30+ years who live > 30
minutes from the nearest breast imaging of any kind, may be disadvantaged for early
detection of breast cancer. This is supported by previous studies have shown that rural
women have a significantly greater likelihood of more advanced stage when diagnosed with
breast cancer than their more urban counterparts [38-40].
For Native American women, geographic access is relatively low for all breast imaging
modalities for a large proportion of the population age 30+ years. In a 2008 Behavioral Risk
Factor Surveillance System (BRFSS) report, mammography rates for Native American
women were lower than for non-Hispanic white women, although the difference was not
large (69% v. 76%, respectively) [41]. This could be due to Native American women finding
ways to overcome barriers to travel time, or could reflect recall bias on the BRFSS survey
instrument, or access to mobile vans, which we were not able to account for in this study.
Interestingly, for Black and urban women, geographic access seems less likely to be a
barrier to screening compared to white and more rural women, respectively. In fact,
comparable screening mammography rates have been shown for Black and White urban
women [42]. However, studies examining utilization of services other than breast imaging
have shown that, among urban cancer patients, Blacks were more likely than Whites to
attend a NCI Cancer Center [43]. Race and rurality do seem to interact as rurality increases,
with odds of attendance at an NCI Cancer Center [11] and use of screening mammography
[42] dropping off significantly for increasingly rural Black individuals compared to
increasingly rural Whites. The geographic component of disparities in health services
utilization and patient outcomes is crucial to understand in order to identify the key causal
factors underlying racial/ethnic disparities in health and health care.
Strengths of our study include calculation of travel time for all three major breast imaging
modalities – mammography, ultrasound, and MRI, whereas prior studies at the national level
have only included mammography, thus not capturing the full range of women's breast
imaging needs and/or experiences. In addition, we characterized geographic access at the
census block group level, rather than county as in prior national scale studies. However, we
do note limitations in this work. First, we were only able to locate breast imaging facilities
within ZIP codes, given the use of claims to identify those services so we were not able to
include the actual address of the facility only the centroid of the census block. We do not
measure time to mobile mammogram facilities, but do recognize that this limitation is
unlikely to apply to our analysis of travel time to ultrasound or breast MRI. Also, as in most
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travel time studies, we used car-based travel estimates, thus did not account for other modes
of transportation, such as subway, and did not explicitly incorporate public bus
transportation into our estimates. Moreover, this analysis assumes that the study population
has access to a vehicle. We also included only the contiguous U.S., thus are leaving out two
states that have a relatively large proportion of native peoples and rural areas. Finally, the
purpose of this study was to describe geographic access broadly, and did not seek to link
access to utilization or outcomes. However, we recognize this as an important next step in
more fully understanding utilization patterns for breast imaging, including
sociodemographic disparities, potential underuse or overuse, and ultimately risk- or
guideline-based care.
Geographic variability in access to breast imaging may be useful information for policy
makers engaged in planning and resource allocation strategies. Understanding access may
provide further insight regarding use/non-use patterns, particularly for subgroups of women
and by imaging modality. For example, from this study we found a very large travel time for
Native American women. Identification of regions, and the populations therein, that are
subject to disadvantages in access can allow for targeted interventions, such as mobile breast
imaging units, or increased availability of transportation services. Information on geographic
access to breast imaging at the population level is an important first step in further
understanding factors contributing to variation in breast cancer care and care outcomes.
Characterizing utilization of breast imaging is an important facet of comparative
effectiveness research for several reasons: 1) necessary to adjust for potential selection bias
in use of imaging when comparing outcomes; 2) identification of subgroups of women for
whom imaging is most effective; and 3) providing parameter inputs in decision analytic
models. A first step in characterizing utilization is to determine potential access to imaging.
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1. Travel time to mammography and ultrasound for most U.S. women (85%) is ≤
20 minutes and 70% for MRI.
2. Native American and rural women have a disproportionately high travel burden
to breast imaging modalities.
3. Black and Asian women had the shortest median travel times to mammography,
ultrasound, and MRI.
4. Characterizing travel time to major breast imaging modalities reveals marked
differences among population subgroups and by modality.
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Table 1
Distribution of travel time to the nearest area with breast imaging services by modality for U.S. women aged
30 years and older (N = 92,788,909).
Travel Time to Nearest Breast Imaging Modality
% U.S. Female Population (30 yrs. and older)
<= 10 minutes >10 - 20 minutes >20 - 30 minutes > 30 minutes
Mammography 67.2 20.2 7.4 5.2
Ultrasound 65.8 20.6 7.8 5.7
MRI 48.7 22.2 9.2 19.8
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Table 2
Median travel times to breast imaging modalities in for the U.S. population of women aged 30 years and older,
by socio-demographic categories.
Median Travel Time in minutes; (Interquartile Range)
N
(%) Total Female Population ages
30+
Mammography Ultrasound MRI
Total Population 92,788,909 6 (4-13) 6 (4-13) 10 (5-26)
Race/Ethnicity1
  White 68,867,272 (74%) 8 (4-15) 8 (4-15) 12 (6-27)
  Black 11,657,643 (13%) 6 (3-9) 6 (3-9) 8 (5-16)
  Pacific 109,922 (0.12%) 6 (4-10) 6 (4-10) 9 (6-15)
  Asian 4,186,628 (4.5%) 5 (3-8) 5 (3-8) 7 (4-12)
  Native American 731,039 (0.79%) 10 (5-27) 11 (5-29) 24 (8-72)
  Other 5,558,618 (6.0%) 5 (3-8) 5 (3-8) 7 (5-13)
 Hispanic 14,619,804 (16%) 5 (3-9) 5 (3-9) 8 (5-14)
Rurality2
  Urban Core 64,012,576 5 (3-8) 5 (3-8) 7 (4-11)
  Suburban Areas 10,859,046 19 (13-26) 19 (13-26) 26 (19-37)
  Large Town Areas 8,966,731 8 (4-18) 9 (4-18) 37 (18-55)
  Small Town and Isolated Rural Areas 8,921,069 21 (10-33) 23 (12-36) 56 (39-80)
Education
  Less than High School 14,849,627 6 (3-12) 6 (3-13) 10 (5-27)
  High School 29,860,888 7 (4-15) 7 (4-15) 12 (6-29)
  Some College 30,198,034 7 (4-13) 7 (4-14) 11 (6-25)
  College 18,025,960 7 (4-12) 7 (4-12) 10 (5-18)
  Graduate/Professional 10,085,461 6 (3-13) 6 (4-11) 9 (5-17)
Median Household Income3
  4th Quartile 27,477,264 7 (4-11) 7 (4-12) 9 (5-16)
  3rd Quartile 24,795,180 7 (4-15) 7 (4-15) 11 (6-26)
  2nd Quartile 22,247,772 7 (4-16) 7 (4-17) 13 (6-39)
  1st Quartile 18,268,692 5 (3-10) 5 (3-10) 9 (5-36)
1
Race and ethnicity are not mutually exclusive counts.
2
419 (0.2%) of census tracts were coded at the county level. 92 census tracts, representing 29,489 women age 30 and over were missing RUCA
codes.
3
Median household income for quartiles: 4th quartile: $35,572 or less; 3rd quartile: >$35,5572-$49,500; 2nd quartile: >$49,500-$69,143; 1st
quartile: >$69,143
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Table 4
Codes used to ascertain breast imaging from Medicare claims.
CODE SOURCE DESCRIPTION
76082 CPT COMPUTER Aided detection Diagnostic Mammogram
76090 CPT MAMMOGRAM, ONE BREAST X-RAY Breast E-C
76091 CPT MAMMOGRAM, BOTH BREASTS X-RAY Breast E-C
G0204 HCPC X-RAY Breast DX MAMMO PRODUC DIR DIGTL
G0205 HCPC X-RAY Breast DIAGNOSTIC MAMMOGRAPHY
G0206 HCPC X-RAY Breast DX MAMMO PRODUC DIR DIGTL
G0207 HCPC X-RAY Breast DIAGNOSTIC MAMMOGRAPHY
76083 CPT COMPUTER Aided detection Screening Mammogram
76085 CPT Digitization of Screening mammogram
76092 CPT MAMMOGRAM, SCREENING X-RAY Breast E-C
77057 CPT Screening mammography, bilateral
G0202 HCPC X-RAY Breast SCR MAMMO PRODUC DIR DIGT
G0203 HCPC X-RAY Breast SCREENING MAMMOGRAPHY
Above plus
S8075 HCPC Computer analysis of full-field digital mammogram and further physician review for interpretation, mammography
77055 CPT Mammography, unilateral
77056 CPT Mammography, bilateral
87.37 ICD9 Other mammography
76645 CPT Breast ultrasound:
76093 CPT MRI Breast, Unil
76094 CPT MRI breast, Bil
77058 CPT MRI, ONE BREAST
77059 CPT MRI, BOTH BREASTS
C8903 HCPC MRI W/CONT, BREAST, UNI
C8904 HCPC MRI W/O CONT, BREAST, UNI
C8905 HCPC MR NO CONTRST FLW W/CNTRS
C8906 HCPC MRI W/CONT, BREAST, BI
C8907 HCPC MRI W/O CONT, BREAST, BI
C8908 HCPC MR NO CONTRST FLW CNTRST
88.73 ICD9 Diagnostic ultrasound of other sites of thorax (includes breast ultrasonography)
77021 CPT Magnetic resonance guidance for needle placement (eg, for biopsy, needle aspiration, injection, or placement oflocalization device) radiological supervision and interpretation
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